Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

Por Pai, Ruth-Anne Langan, Japp, Alberto Sada, Gonzalez, Michael, Rasheed, Rozena F., Okumura, Mariko, Arenas, Daniel, Pierson, Sheila K., Powers, Victoria, Layman, Awo Akosua Kesewa, Kao, Charlly, Hakonarson, Hakon, van Rhee, Frits, Betts, Michael R., Kambayashi, Taku, Fajgenbaum, David C.
Publicado no JCI Insight (2020)

Increased mTOR activation in idiopathic multicentric Castleman disease

Por Arenas, Daniel J., Floess, Katherine, Kobrin, Dale, Pai, Ruth-Anne Langan, Srkalovic, Maya B., Tamakloe, Mark-Avery, Rasheed, Rozena, Ziglar, Jasira, Khor, Johnson, Parente, Sophia A. T., Pierson, Sheila K., Martinez, Daniel, Wertheim, Gerald B., Kambayashi, Taku, Baur, Joseph, Teachey, David T., Fajgenbaum, David C.
Publicado no Blood (2020)

Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review

Por Fajgenbaum, David C., Khor, Johnson S., Gorzewski, Alexander, Tamakloe, Mark-Avery, Powers, Victoria, Kakkis, Joseph J., Repasky, Mileva, Taylor, Anne, Beschloss, Alexander, Hernandez-Miyares, Laura, Go, Beatrice, Nimgaonkar, Vivek, McCarthy, Madison S., Kim, Casey J., Pai, Ruth-Anne Langan, Frankl, Sarah, Angelides, Philip, Jiang, Joanna, Rasheed, Rozena, Napier, Erin, Mackay, Duncan, Pierson, Sheila K.
Publicado no Infect Dis Ther (2020)